PMS2 Recombinant Rabbit Monoclonal Antibody: From Molecular Mechanism to Precision Diagnostic Applications

Literature Information

This paper systematically elaborates the biological function of PMS2, the core role of PMS2 recombinant rabbit monoclonal antibodies in DNA mismatch repair (MMR) research and clinical diagnosis, as well as their technical advantages, production principles, systematic validation standards, and typical applications in Lynch syndrome screening and tumor immunotherapy guidance. It also highlights the high-performance PMS2 antibody developed by ANT BIO PTE. LTD. under its Starter sub-brand, which provides critical technical support for precision oncology research.

Research Background

Genome stability is the foundation of normal cell function, and the DNA mismatch repair (MMR) system is a core defense mechanism against DNA replication errors. As a key component of the MMR system, PMS2 (PMS1 homolog 2) forms a heterodimer MutLα with MLH1, participating in mismatch recognition, single-strand DNA cleavage, and error correction.

Defects in PMS2 function lead to microsatellite instability (MSI), closely linked to hereditary nonpolyposis colorectal cancer (Lynch syndrome) and various sporadic tumors (endometrial, gastric, ovarian cancer, etc.). Tumors with PMS2 deficiency exhibit significant sensitivity to PD-1/PD-L1 immune checkpoint inhibitors.

In clinical practice, immunohistochemistry (IHC) for MMR proteins (MLH1, MSH2, MSH6, PMS2) is the gold standard for Lynch syndrome screening and immunotherapy stratification. Traditional mouse monoclonal antibodies suffer from low sensitivity, poor specificity, and unstable batch consistency, while recombinant rabbit monoclonal antibodies overcome these bottlenecks, becoming the preferred tool for PMS2 detection in the precision medicine era.

Research Ideas

The research adopts a multi-dimensional analytical framework to explore PMS2 recombinant rabbit monoclonal antibodies:

1. Clarify the molecular characteristics of PMS2 protein and its core role in MMR and tumor pathogenesis.

2. Compare the technical advantages of recombinant rabbit monoclonal antibodies over traditional mouse antibodies in specificity, affinity, and batch consistency.

3. Elaborate the preparation process of PMS2 recombinant rabbit monoclonal antibodies based on genetic engineering and mammalian cell expression systems.

4. Establish a systematic validation system covering Western blot, IHC, and cross-reactivity assays to evaluate antibody performance.

5. Summarize the clinical applications of PMS2 antibodies in Lynch syndrome screening and tumor immunotherapy guidance.

6. Introduce the high-quality PMS2 recombinant rabbit monoclonal antibody from ANT BIO PTE. LTD. and its core application value.

Research Results

1. PMS2 Protein and MMR Mechanism: PMS2 (96 kDa, 862 amino acids) is encoded by the 7p22 gene. It forms MutLα with MLH1, activates endonuclease activity, and corrects replication errors via EXO1. PMS2 deficiency causes MSI, driving tumorigenesis and predicting immunotherapy response.

2. Technical Advantages of Recombinant Rabbit mAbs:

3. Antibody Preparation Innovation: Animal-free production via B cell isolation, antibody gene cloning, and HEK293 expression avoids hybridoma drift, ensuring high purity and stable performance.

4. Systematic Validation Standards:

o Western Blot: Specifically detects 96 kDa PMS2 in multiple cell lines (U2OS, HeLa, A549) with no non-specific bands.

o IHC: Optimized for FFPE samples, showing clear nuclear staining; distinguishes true PMS2 loss from MLH1-dependent degradation.

o Cross-reactivity: No binding to MLH1, MSH2, or MSH6, ensuring diagnostic accuracy.

5. Clinical Application Breakthroughs:

o Lynch Syndrome Screening: Combined IHC detection of MLH1/MSH2/MSH6/PMS2 identifies hereditary tumors, guiding family genetic counseling.

o Immunotherapy Guidance: PMS2-deficient tumors have 3–5 times higher response rates to PD-1 inhibitors, enabling precise patient stratification.

Product Empowerment

ANT BIO PTE. LTD., through its sub-brand Starter (specializing in antibody development), has independently developed the PMS2 Recombinant Rabbit Monoclonal Antibody (SDT-111-307), a high-performance detection antibody optimized for IHC, Western blot, and immunoprecipitation. This product delivers robust support for MMR research and clinical diagnosis, with specific contributions as follows:

1. High Specificity & Sensitivity: Developed via recombinant rabbit monoclonal technology, it targets a conserved epitope of PMS2 (aa 550–600). It specifically recognizes endogenous PMS2 with minimal cross-reactivity to other MMR proteins, accurately distinguishing true PMS2 loss from secondary degradation.

2. Superior IHC Performance: Optimized for FFPE tissue sections (1:100–1:200 dilution), it produces clear nuclear staining with low background. It complies with NordiQC standards, ensuring consistent and reliable results across different laboratories.

3. Broad Application Compatibility: Validated for Western blot (1:1000 dilution), immunoprecipitation, and cell immunofluorescence. It detects PMS2 in multiple human cell lines and tumor tissues, supporting basic research and clinical diagnostic applications.

4. Excellent Batch Stability: Produced via HEK293 expression with a defined sequence, it eliminates batch-to-batch variation. Supplied in liquid form (40% glycerol), it maintains long-term activity without repeated freeze-thaw damage.

Brand Mission

ANT BIO PTE. LTD. is a leading enterprise dedicated to providing high-quality life science reagents and precision diagnostic tools. With three specialized sub-brands—Absin (focused on general reagents and kits), Starter (specialized in antibodies), and UA (focused on recombinant proteins)—we deliver rigorously validated, high-performance antibodies for tumor research, genetic diagnosis, and precision medicine. Adhering to the core philosophy of "quality-driven, innovation-led, customer-focused," we are committed to addressing key technical bottlenecks in MMR detection and Lynch syndrome screening, empowering global researchers and pathologists to advance precision oncology and improve patient outcomes.

Related Product List

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.